Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011‐2016
G.K. Balasubramani(University of Pittsburgh), Richard K. Zimmerman(University of Pittsburgh), Emily T. Martin(University of Michigan), Brendan Flannery(Centers for Disease Control and Prevention), Emily Bobyock(University of Pittsburgh), Theresa M. Sax(University of Pittsburgh), Joe Suyama(University of Pittsburgh), Jessie R. Chung(Centers for Disease Control and Prevention), Mary Patricia Nowalk(University of Pittsburgh), Michael L. Jackson(Kaiser Permanente Washington Health Research Institute), Charles R. Rinaldo(University of Pittsburgh), Manjusha Gaglani(Baylor Scott & White Health), Arnold S. Monto(University of Michigan)
Cited by 10
Related Papers
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the <i>CKR5</i> Structural Gene
|Science|1996|2.5k
Consistent Viral Evolutionary Changes Associated with the Progression of Human Immunodeficiency Virus Type 1 Infection
|Journal of Virology|1999|956
Incidence of Pneumococcal Disease Due to Non–Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004
|The Journal of Infectious Diseases|2007|747
High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors
|Journal of Virology|1995|513
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19
|Clinical Infectious Diseases|2020|501